Form 8-K - Current report:
SEC Accession No. 0001213900-25-055188
Filing Date
2025-06-17
Accepted
2025-06-17 16:15:49
Documents
13
Period of Report
2025-06-17
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea024600601-8k_abprohold.htm   iXBRL 8-K 26124
  Complete submission text file 0001213900-25-055188.txt   237179

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abp-20250617.xsd EX-101.SCH 3887
3 XBRL DEFINITION FILE abp-20250617_def.xml EX-101.DEF 26777
4 XBRL LABEL FILE abp-20250617_lab.xml EX-101.LAB 36995
5 XBRL PRESENTATION FILE abp-20250617_pre.xml EX-101.PRE 25401
15 EXTRACTED XBRL INSTANCE DOCUMENT ea024600601-8k_abprohold_htm.xml XML 6001
Mailing Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013
Business Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013 248-890-7200
Abpro Holdings, Inc. (Filer) CIK: 0001893219 (see all company filings)

EIN.: 871013956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41224 | Film No.: 251053489
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)